John McKinley

John has over three decades’ experience of board-level executive and NED chairman roles in private and publicly listed companies, government departments including public private industry partnerships in the UK and overseas. He has specialist expertise in diagnostic technologies, instruments and devices, particularly in highly infectious respiratory human and animal diseases, with a deep knowledge of translational population genomics and personalised medicine. John transitioned from a foundation career in corporate, commercial and licensing legal practice, the London insurance industry and ESG technologies to executive roles in global Life Science, biotechnology and environmental sector companies. Seasoned in engaging executives, shareholders and stakeholders at all levels of seniority, he articulates visions for business improvement and ESG aligning disparate parties towards common purposes and goals. As a result, he has launched and led a variety of companies from start-up to become publicly listed entities with robust ESG governance and expansive global commercial footprints. John’s insights into global healthcare policies, practical translational expertise and senior legal background will help guide Impex’s mission to become the global leader in next-generation breath diagnostics.